Last: | $14.99 |
---|---|
Change Percent: | -0.07% |
Open: | $15 |
Close: | $14.99 |
High: | $15 |
Low: | $14.99 |
Volume: | 860,515 |
Last Trade Date Time: | 11/30/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$14.99 | $15 | $14.99 | $15 | $14.99 | 860,515 | 11-30-2023 |
$15.01 | $14.84 | $15.01 | $15.07 | $14.84 | 2,700,914 | 11-29-2023 |
$14.84 | $14.84 | $14.84 | $14.86 | $14.84 | 264,955 | 11-28-2023 |
$14.84 | $14.82 | $14.84 | $14.88 | $14.82 | 260,522 | 11-27-2023 |
$14.82 | $14.82 | $14.82 | $14.84 | $14.8 | 143,066 | 11-24-2023 |
$14.82 | $14.8 | $14.82 | $14.83 | $14.79 | 99,956 | 11-23-2023 |
$14.82 | $14.8 | $14.82 | $14.83 | $14.79 | 99,956 | 11-22-2023 |
$14.79 | $14.76 | $14.79 | $14.82 | $14.76 | 374,240 | 11-21-2023 |
$14.79 | $14.82 | $14.79 | $14.82 | $14.77 | 475,934 | 11-20-2023 |
$14.79 | $14.67 | $14.79 | $14.79 | $14.665 | 598,296 | 11-17-2023 |
$14.65 | $14.7 | $14.65 | $14.7 | $14.63 | 677,673 | 11-16-2023 |
$14.68 | $14.65 | $14.68 | $14.73 | $14.65 | 317,115 | 11-15-2023 |
$14.68 | $14.71 | $14.68 | $14.8 | $14.61 | 693,966 | 11-14-2023 |
$14.61 | $14.85 | $14.61 | $14.87 | $14.41 | 1,943,293 | 11-13-2023 |
$14.85 | $14.85 | $14.85 | $14.86 | $14.84 | 282,148 | 11-10-2023 |
$14.83 | $14.85 | $14.83 | $14.85 | $14.82 | 40,976 | 11-09-2023 |
$14.83 | $14.89 | $14.83 | $14.89 | $14.8175 | 253,869 | 11-08-2023 |
$14.87 | $14.89 | $14.87 | $14.89 | $14.82 | 137,121 | 11-07-2023 |
$14.84 | $14.89 | $14.84 | $14.89 | $14.84 | 39,453 | 11-06-2023 |
$14.86 | $14.87 | $14.86 | $14.9 | $14.81 | 307,825 | 11-03-2023 |
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) Vancouver, BC – TheNewswire - July 8, 2024 - Goldhills Holding Ltd. (TSXV:GHL ) ( OTCQB: GODZF ) ( Frankfurt: GRYA) (“Goldhills” or the "Company") is pleased to announce that it has closed its previously anno...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...